Listed

Immuneering Corp: Form 10-K for the period ended Dec 31, 2021

Filed with the SEC on Mar 10, 2022 and accepted by EDGAR at Mar 10, 2022, 06:38 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2021-01-01 to 2021-12-31$2.1mus-gaap:Revenues
Cost of revenue12 months2021-01-01 to 2021-12-31$1.2mus-gaap:CostOfRevenue
Gross profit12 months2021-01-01 to 2021-12-31$926.9kus-gaap:GrossProfit
Research and development12 months2021-01-01 to 2021-12-31$26.5mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2021-01-01 to 2021-12-31−$33.9mus-gaap:OperatingIncomeLoss
Income tax12 months2021-01-01 to 2021-12-31−$307.5kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2021-01-01 to 2021-12-31−$33.5mus-gaap:NetIncomeLoss
Diluted EPS12 months2021-01-01 to 2021-12-31−$2.46us-gaap:EarningsPerShareDiluted
Basic EPS12 months2021-01-01 to 2021-12-31−$2.46us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2021-01-01 to 2021-12-3113,612,677 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2021-01-01 to 2021-12-31−$30.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2021-01-01 to 2021-12-31$60.8kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-12-31$74.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-12-31$152.3mus-gaap:AssetsCurrent
Total assetsAt period end2021-12-31$166.7mus-gaap:Assets
Current liabilitiesAt period end2021-12-31$5.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-12-31$10.7mus-gaap:Liabilities
Shareholders' equityAt period end2021-12-31$156.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-22-003208. Last ingested by Listed: Nov 10, 2026, 03:06 ET. Listed shows no prices and gives no investment advice.